A clinical study reported a significant difference in expression of cytoplasmic CD40 between breast cancer subtypes, and cytoplasmic expression of CD40 is related to a better prognosis [85], which suggest that CD40 may have potential as a new prognostic factor in breast cancer. Here, CD40 is linked to breast cancer.